# Investor Profile — Matt Hoffmann ## Phase 1: Risk & Horizon ✅ ### Time Horizon - **Primary capital:** 15-20 years (mid-30s now, targeting retirement by ~50) - **Sub-accounts:** Separate capital allocation for "moonshots and ten baggers" — suggests a barbell approach: core + speculation - **Inheritance expectation:** 7-figure range, timeline TBD ### Risk Tolerance: 8-10 (High) - Self-reported aggressive risk profile - Comfort with volatility, guided by "blood in the streets" philosophy - Macro-driven anxiety present but managed through conviction - History of doubling down on high-conviction positions ### Drawdown Experience - **TSLA:** Held since 2018, bought through drawdowns - Pattern: averages *up* on conviction, not just down - Behavioral note: high-conviction accumulator — rare profile, higher risk of anchor bias ### Sleep Factor Analysis - **What keeps him up:** FOMO on melt-ups, tail risk of ruin - **What helps him sleep:** Time horizon youth advantage, "blood in the streets" mantra - **Tension:** Simultaneously afraid of missing upside AND going to zero — classic barbell psychology --- ## Phase 2: Income & Cash Flow ✅ ### Savings Rate - **401(k)/403(b):** 15% of gross income - **Taxable brokerage:** 5% of gross income - **Total investment rate:** 20% of gross — solid foundation ### Income Needs - **Current portfolio income:** None — pure accumulation - **Goal:** Maximal compounding, early retirement by ~50 ### Liquidity & Emergency Fund - **Emergency reserve:** 6+ months income in HYSA/CD ladders - **Liquidity buffer:** "Sufficient to cover known and unknown expenses" - **12-24 month major outflows:** Unlikely ### Inheritance Timing - **Expected horizon:** Hopefully 20+ years (parents in good health) - **Financial planning implication:** Treat as tailwind, not base case. Cannot rely on it for retirement-by-50 math. --- ## Phase 3: Sectors & Convictions ✅ ### Domain Knowledge - **Tech / AI / Hyperscalers:** Primary competency — works in related field - **Fintech:** Strong understanding - **Healthcare / Biotech / Pharma:** Moderate depth via professional exposure + self-directed reading ### Sector Avoidance - **Traditional blue-chip "boring" stocks:** Actively uninterested - **Legacy auto:** Believes structural decline, but notes EV space has "zombie companies" too - **Retail:** "Race to the bottom" — commodity/competitive dynamics ### Best Investment Decision - **Philosophical win:** Consistent early investing habit - **Stock win (largest on paper):** TSLA — held since 2018, bought through drawdowns - **Stock win (most proud of):** LLY — identified GLP-1 opportunity early, demonstrated independent thesis generation - **Key lesson:** Conviction + timing + patience = alpha ### Worst Investment Decision - **PLTR:** Bought at $30, tax-loss harvested at $7, never re-entered - **Current price context:** ~10x from exit — the "one that got away" - **Behavioral scar:** Selling at the bottom for tax reasons, then failing to re-evaluate - **Key lesson:** Tax-loss harvesting without re-entry plan can crystallize permanent loss of upside ### Portfolio Composition Note - TSLA appears to be primary individual stock holding - LLY also held (exact sizing TBD) - Pattern: concentrated high-conviction positions in disruptive technology + healthcare innovation --- ## Phase 4: Behavioral Profile ✅ ### Response to Drawdowns - **Default behavior:** Average down or hold — rarely sells losers - **TSLA history confirms:** Bought through drawdowns since 2018 - **Risk:** Situational averaging down without systematic stop/reassessment rules → potential for catching falling knives - **PLTR lesson:** Sold at $7 for tax loss, never re-entered — but this was an exception, not the norm ### Portfolio Monitoring Frequency - **Frequency:** Daily, sometimes hourly during market hours - **Implication:** High monitoring = higher emotional reactivity risk - **Mitigation needed:** Explicit rebalancing rules to reduce real-time decision load ### Leverage Exposure - **Current:** None — no margin, options, or leveraged products - **Interest level:** Curious, wants to learn with guidance - **Opportunity:** Structured options education (income generation / risk management, not speculation) - **Risk flag:** High monitoring + leverage curiosity = need for guardrails before introduction ### Concentration vs. Diversification — Barbell Execution - **Core (403b):** Highly diversified — ETFs, mutual funds, Vanguard products. This is the "safe" barbell end. - **Satellite (fun account):** Wildly imbalanced, concentrated in "multiplier" stocks - **Single-position comfort zone:** Clearly >25% in practice (TSLA + LLY) - **Structural insight:** The barbell is real — but the satellite book may be *too* concentrated without position-sizing rules --- ## Phase 5: Constraints & Preferences ✅ ### Vehicle Preferences - **Core book:** ETFs, mutual funds, Vanguard products (403b) - **Satellite book:** Individual equities — TSLA, LLY, others - **Missing exposure:** Options strategies — interested in learning, considering Robinhood account for experimentation - **Note:** Options education opportunity flagged; should be structured (income/risk management, not speculation) ### Hard Restrictions - **None** — no employer trading restrictions - **Crypto stance:** Leery of "moonshot" altcoins (space "played out") but not ideologically opposed to BTC - **No BTC maximalism** — open to crypto as an asset class but skeptical of speculative tokens ### Tax Optimization — UPDATE 2026-05-04 **Status:** Partially actionable #### Roth IRA Backdoor — ✅ VIABLE - No existing traditional IRA = clean backdoor path - Contribute $6,500 to traditional IRA (non-deductible) - Immediately convert to Roth = no pro-rata issues - **Action:** Open traditional IRA, fund $6,500, convert to Roth same week - **Value:** $6,500/year × 15 years = $97,500 principal + tax-free growth on ~$150K+ future value - **Priority:** HIGH. Do this for 2026 if deadline not passed (April 15, 2027). #### HSA — ❌ NOT ELIGIBLE - No-deductible family plan ≠ high-deductible health plan - Cheaper premium = standard PPO/HMO style plan - HSA requires HDHP specifically - **Alternative:** Evaluate if HDHP + HSA is cheaper overall (premium + out-of-pocket vs. tax savings) - At $208K income, tax savings on $8,300 HSA contribution = ~$2,900 federal + state - If premium difference < $2,900/year, HDHP+HSA may still win #### TSLA Transfer — 🟡 IN PROGRESS - Advisor exploring options - If possible: move to options-enabled brokerage for covered calls - If not possible: explore other monetization (margin loan against TSLA?) #### Donor-Advised Fund — ⏰ DEFERRED - Appetite for structured philanthropy in senior years - Note: Best time to donate appreciated stock = during high-income years (now) - Deferring to lower-income retirement years reduces deduction value - **Recommendation:** If charitable giving increases, revisit before retirement #### Tax-Loss Harvesting — ✅ IMMEDIATE OPPORTUNITY - PYPL likely underwater - Scan all taxable positions for unrealized losses - Value: $3K/year ordinary income offset + gains offset - **Anti-PLTR protocol:** Every tax-loss sale needs written re-entry plan --- ## Current Tax-Advantaged Space Utilization | Account | Annual Limit | Current Contribution | Utilization | |---------|-------------|---------------------|-------------| | 403(b) | $23,000 (2026) | ~$31,275 (15% of $208K) | ✅ OVER (via employer match?) | | Roth IRA (backdoor) | $6,500 | $0 | ❌ MISSING | | HSA | $8,300 | $0 | ❌ INELIGIBLE | | Taxable | Unlimited | ~$10,425 (5% of $208K) | ⚠️ UNNECESSARY | **Observation:** You're contributing ~$31K to 403b + $10K to taxable = $41K total - If 403b limit is $23K, excess may be after-tax contributions or employer match - Need to clarify: is the $31K all pre-tax, or mix of pre-tax + after-tax? --- ## Immediate Tax Action Items (Next 30 Days) 1. **Open traditional IRA** → Fund $6,500 → Convert to Roth (backdoor) - Deadline: April 15, 2027 for 2026 contribution - Platform: Vanguard, Fidelity, Schwab - Time: 30 minutes online 2. **Tax-loss harvest scan** - Review all taxable positions for unrealized losses - PYPL top candidate - Implement before year-end 3. **Clarify 403(b) contribution structure** - Pre-tax vs. after-tax vs. Roth 403b? - Employer match included in $31K? 4. **Evaluate HDHP + HSA math** - Premium difference vs. tax savings - Aundrea's VA benefits may reduce HDHP risk --- ## Projected Tax Savings (15-Year Horizon) | Strategy | Annual Value | 15-Year Value | |----------|-------------|---------------| | Roth IRA backdoor | $2,000 (tax-free growth benefit) | ~$30,000 | | Tax-loss harvesting | $1,000-3,000/year | ~$22,500-45,000 | | 403b optimization | TBD after clarification | TBD | | **Total estimated** | **$3,000-5,000/year** | **$45,000-75,000** | --- *Tax optimization status: Partially actionable. Roth backdoor + tax-loss harvest are immediate wins. HSA blocked by plan type. TSLA transfer pending.* ### ESG / Ethical Exclusions - **None.** "If it earns a buck, I don't give a fuck." - **Implication:** Full universe available for analysis. No sector exclusions on moral grounds. --- ## Profile Summary ### Investment DNA - **Age:** Mid-30s | **Target retirement:** ~50 (15-year horizon) - **Risk tolerance:** 8-10/10 | **Savings rate:** 20% gross - **Horizon advantage:** Young enough to survive macro cycles - **Inheritance:** 7-figure expectation, 20+ year timeline — tailwind, not base case ### Strategy Architecture - **Barbell approach confirmed:** - Left end (safety): 403b with diversified ETFs/mutual funds (~50% of assets) - Right end (aggression): Taxable brokerage with concentrated high-conviction singles (~50% of assets) - **Core competency sectors:** Tech, AI, hyperscalers, fintech, healthcare/biotech - **Avoided sectors:** Legacy auto, traditional retail, "boring" blue chips ### Behavioral Profile - **Monitoring:** Daily/hourly — high emotional reactivity risk - **Drawdown response:** Average down or hold — rarely sells losers - **Concentration comfort:** >25% in single names in practice - **Leverage:** None currently, curious about options - **Key scar:** PLTR — tax-loss sold at bottom, never re-entered, missed 10x ### Key Risks Identified 1. **Anchor bias on TSLA:** 8-year holding, multiple buy-ins = large embedded position. Quantified at 32.4% of taxable account. MITIGATED: Not 40%+ as feared. Within defensible range for high-conviction investor, but needs monitoring. 2. **FOMO/Ruin paradox:** Simultaneous fear of missing melt-up AND going broke → needs explicit risk budget 3. **Hourly checking + no sell discipline:** BEHAVIORAL CORRECTION NEEDED. Director DOES sell — in stages (LLY: sold half, then half again). Not "no sell discipline," but "staged exit discipline." Still creates rebalancing gaps. 4. **Options curiosity + high monitoring:** Dangerous combo without guardrails. Education IN PROGRESS. Week 1 CSP paper trade active. 5. **No tax-advantaged accounts beyond 403b:** Missing Roth IRA, HSA opportunities at peak earning years. 403b = TransAmerica passively managed with international ETFs. International exposure covered there. ### Immediate Opportunities 1. **Options education:** Week 1 CSP on RIVN active. Curriculum structured. 2. **Position sizing rules:** TSLA at 32.4% — define hard cap (suggest 30-35%). TSLA tax bomb ($57,760 unrealized gain) makes selling expensive; covered calls become attractive monetization tool. 3. **Tax optimization:** Evaluate Roth IRA + HSA for additional tax-advantaged space 4. **Retirement-by-50 modeling:** COMPLETE. Base case 55, upside 50-52 (inheritance-dependent), stretch 48-50. 5. **"Moonshot" boundary:** Explicitly define what % of satellite book goes to asymmetric bets. RGTI at 0% currently — on watchlist. 6. **Portfolio self-image update:** Director is "tech-weighted generalist with ETF core," NOT "reckless tech barbell." Own this. ### Next Steps - [x] Model retirement-by-50 feasibility with current trajectory → COMPLETE - [x] Quantify TSLA/LLY position sizes vs. total portfolio → COMPLETE (TSLA 32.4%, LLY 2.0%) - [x] Draft options learning plan → COMPLETE (12-week curriculum, Week 1 active) - [ ] Evaluate Roth IRA + HSA eligibility and contribution limits - [x] Set up trade journaling process for satellite book → COMPLETE (2026-05-04-RIVN-CSP-paper.md) - [ ] Complete portfolio snapshot questions (international, TSLA cost basis, LLY sizing, TSN thesis, PYPL status) → COMPLETE --- ## DIRECTOR CHALLENGES — Blind Spots & Misunderstandings ### Challenge #1: "I Never Sell Losers" → FALSE **Evidence:** LLY sold half, then half again. PYPL likely underwater but still held. TSLA not trimmed despite 89.5% gain. **Reality:** You sell WINNERS in stages (LLY) and HOLD losers (PYPL?). This is the OPPOSITE of optimal. Winners should run, losers should be cut. **The fix:** Define " trim rules" for winners (e.g., trim at +100%, +200%) and "cut rules" for losers (e.g., -30% = reassess, -50% = cut unless thesis revolutionized). ### Challenge #2: "I'm a Tech-Only Investor" → FALSE **Evidence:** TSN (protein/value), SCHW (financial), CCJ (uranium/energy), VPU (utilities), COST (retail). **Reality:** You buy ANYTHING with a clear thesis. Tech is your comfort zone, not your prison. **The fix:** Own this. You're a generalist. It makes you better, not worse. Stop apologizing for non-tech holdings. ### Challenge #3: "I Have No Sell Discipline" → PARTIALLY FALSE **Evidence:** LLY staged exits show discipline. But TSLA at 89.5% gain with no trim plan = letting winners ride TOO long. **Reality:** You sell when the story changes (LLY: GLP-1 market matured, position right-sized). You don't sell when the price gets "too high" (TSLA). **The fix:** Price-based rebalancing rules, not story-based. TSLA at 35% of portfolio = mandatory trim, regardless of FSD/robotaxi/Optimus narrative. ### Challenge #4: "My Barbell is Safe/Aggressive Split" → OVERSIMPLIFIED **Evidence:** 403b is diversified (true safe end). Taxable is 56% individual equities + 41% ETFs + 3% cash. **Reality:** Your "aggressive" end is more balanced than you think. VTI/VB/IJJ/VO = 38% of taxable alone. That's not a pure satellite book. **The fix:** Your barbell has a FAT middle. That's good. It means your risk is lower than your self-image suggests. But it also means you're not as aggressive as you think — which affects return expectations. ### Challenge #5: "Blood in the Streets = Buy More" → UNDEFINED **Evidence:** TSLA 2018-2022 drawdowns = bought through. But no rules on WHEN to stop averaging down. **Reality:** "Blood in the streets" is a philosophy, not a system. Without a max position size or max loss per name, it becomes catching falling knives. **The fix:** For every "blood in the streets" buy, define: (a) max % of portfolio this name can reach, (b) max $ loss before thesis is declared broken, (c) re-entry plan if you sell for tax loss (anti-PLTR protocol). ### Challenge #6: "Retirement-by-50 is My Goal" → NEEDS RISK ADJUSTMENT **Evidence:** Base case math = 55 without inheritance. You said "plan for 55" but your gut wants 50. **Reality:** The gap is ~$5M at moderate returns. Inheritance is the variable, not your savings rate. **The fix:** Treat retirement age as a RANGE with probabilities, not a binary. Base case 55 (50%), upside 52 (30%), stretch 50 (20%). This reduces FOMO without reducing motivation. ### Challenge #7: "Options Are for Income/Dabbling" → UNDERESTIMATING COMPLEXITY **Evidence:** Week 1 CSP on RIVN = good start. But "daily/hourly checking" + options = emotional decay acceleration. **Reality:** Options are a TOOL, not a toy. They amplify both returns AND stress. Your monitoring frequency makes you susceptible to overtrading. **The fix:** Options trades get a "no-touch" rule. Once entered, no adjustments unless price hits predefined triggers. No "let me check how it's doing" checks. Theta works silently — don't interrupt it. --- ## Midas's Explicit Guidance & Challenge Matrix | Your Self-Image | The Data Says | My Guidance | My Challenge | |-----------------|---------------|-------------|--------------| | "I never sell" | You sell winners in stages (LLY) | Define trim rules for winners | Why hold PYPL if thesis broken? | | "Tech only" | 9 sectors represented | Own your generalist skill | Why avoid international in taxable? | | "Reckless barbell" | 41% ETFs in taxable + 50% in 403b | Your risk is lower than you think | Are you okay with lower returns? | | "Blood in streets buyer" | No stop rules, no max size | Define position caps and loss limits | What if TSLA drops 50% from here? | | "Retire by 50" | Base case = 55 without inheritance | Plan for range, not binary | Can you emotionally accept 55? | | "Options dabbler" | Hourly monitoring = overtrading risk | Pre-defined triggers only | Can you NOT check RIVN for 24 hours? | --- ## Updated Portfolio Snapshot (Taxable) **Total:** $198,913.51 - Individual equities: ~56% (TSLA 32.4% dominant) - ETFs: ~41% (VTI 17.7%, VB 10.7%, IJJ 9.3%, VPU 2.4%, VO 0.6%) - Cash/money market: ~3% **Key holdings:** - TSLA: $64,485 (32.4%), cost basis ~$40.75/share, unrealized gain $57,760 - LLY: $3,945 (2.0%) — reduced via staged exits, would rebuild on dip - CCJ: $4,276 (2.2%) — already owned, CSP candidate flagged for concentration risk - PYPL: $6,193 (3.1%) — M&A thesis, appropriately sized binary bet - TSN: $5,205 (2.6%) — value play, below book entry, protein/inflation thesis --- ## Active Trades / Watchlist **Week 1 Paper Trade:** - RIVN $13 Put, June 18, 2026 — $0.40 premium collected - Status: OPEN - Next check: Wednesday 2026-05-06 **Watchlist:** - CCJ: CSP candidate (but already own 2.2% — concentration risk) - RGTI: CSP candidate (speculative, aligns with moonshot interest) - TSLA: Covered call candidate (tax-efficient monetization, shares in different brokerage) **Market Regime:** Late-cycle expansion. VIX 17.86, yield curve +50bps, HY spreads 284bps (tight). Tech lagging, energy/materials leading. --- *Profile updated: 2026-05-04 (with portfolio quantification + behavioral corrections)* *Revisit quarterly or upon major life/financial changes*